Italian biotech company Amplimedical signs on as Roche's new PCR licensee:
This article was originally published in Clinica
Executive Summary
Amplimedical, the Italian biotechnology company, has gained non-exclusive worldwide licence to Roche Diagnostic's real-time PCR technology. Milan-based Amplimedical plans to use this deal to expand further its product portfolio - of which nearly half comprise real-time assays - and become a major supplier of highly automated and rapid diagnostic technology.